Nobel Prize in Physiology or Medicine 2018

  • ChemPubSoc Europe Logo
  • Author: ChemViews Magazine (Photos: wikimedia commons, Gerbil, CC BY-SA 3.0, and 大臣官房人事課, CC-BY 4.0)
  • Published Date: 01 October 2018
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Nobel Prize in Physiology or Medicine 2018

The Nobel Prize in Physiology or Medicine 2018 has been awarded jointly to

  • James P. Allison (pictured left), University of Texas MD Anderson Cancer Center, Houston, TX, USA, and
  • Tasuku Honjo (pictured right), Kyoto University, Japan,

"for their discovery of cancer therapy by inhibition of negative immune regulation."


The researchers' work led to a completely new principle of cancer treatment, which takes advantage of the immune system’s ability to attack cancer cells. They have developed strategies for inhibiting certain "brakes" on the immune system and stimulating its ability to fight cancer. The resulting cancer treatments, often referred to as "immune checkpoint therapy", have shown remarkable results.


James P. Allison studied a known protein, CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), which functions as a brake on the immune system's T cells. He realized the possibility of "releasing" this brake by using an antibody that can bind to CTLA-4, block its function, and allow the immune cells to attack cancer. He then developed this concept into an approach for treating patients.


Tasuku Honjo discovered PD-1 (programmed cell death protein 1), another protein on the surface of T-cells. He revealed that it also operates as a brake, but with a different mechanism of action. Therapies based on his discovery proved to be very effective in the fight against cancer.


James P. Allison, born in 1948 in Alice, TX, USA, received his Ph.D. from the University of Texas, Austin, USA, in 1973. From 1974 to1977, he was a Postdoctoral Researcher at the Scripps Clinic and Research Foundation, La Jolla, CA, USA. He then served as a Faculty Member at the University of Texas System Cancer Center, Smithville, USA. From 1985 to 2004, he was a Faculty Member at the University of California, Berkeley, USA, and from 2004 to 2012, he worked at Memorial Sloan-Kettering Cancer Center, New York, USA. He then was as an Investigator at the Howard Hughes Medical Institute, Chevy Chase, MD, USA. Since 2012, Allison has served as Professor at the University of Texas MD Anderson Cancer Center. He is also affiliated with the Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.


Tasuku Honjo, born in 1942 in Kyoto, Japan, received his M.D in 1966. From 1971 to 1974, he was a Research Fellow at the Carnegie Institution of Washington (CIW), Baltimore, and at the National Institutes of Health (NIH), Bethesda, both MD, USA. He received his Ph.D. from Kyoto University in 1975. From 1974 to 1979, he was Assistant Professor of Medicine at Tokyo University, and from 1979 to 1984, he was Professor of Genetics at Osaka University, both Japan. Since 1984, he has served as Professor at Kyoto University.


 

Selected Publications by James P. Allison


Selected Publications by Tasuku Honjo


Also of Interest

 

Article Views: 1584

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH